By Anemia is one of the most common findings in routine bloodwork – and one of the most commonly misunderstood. People assume it means iron deficiency. Or they assume it’s always serious. Or they assume it explains every symptom they’ve been having. Often, none of these assumptions are correct.
Here’s the most important thing to understand from the start: anemia is not a diagnosis. It’s a sign – a finding that tells you something about what’s happening in the blood, but not why it’s happening. Getting the “why” right is what determines the treatment, the prognosis, and whether something more serious needs to be investigated.
This article covers what anemia actually is, how the body’s red blood cell system works, the main categories of anemia, how the CBC guides diagnosis, symptoms, and what the clinical approach looks like.
What Anemia Is – and What It Isn’t
Anemia is defined as a reduction in the blood’s oxygen-carrying capacity, most commonly measured through hemoglobin concentration. Hemoglobin is the iron-containing protein inside red blood cells (RBCs) that binds oxygen in the lungs and delivers it to tissues throughout the body.
WHO diagnostic thresholds for anemia (hemoglobin below):
| Population | Anemia Threshold |
|---|---|
| Men (adult) | 13.0 g/dL |
| Non-pregnant women (adult) | 12.0 g/dL |
| Pregnant women | 11.0 g/dL |
| Children 6-59 months | 11.0 g/dL |
| Children 5-11 years | 11.5 g/dL |
| Children 12-14 years | 12.0 g/dL |
These thresholds reflect the level below which oxygen delivery to tissues becomes physiologically compromised. But anemia exists on a spectrum – mild anemia may cause no noticeable symptoms; severe anemia can be life-threatening.
What anemia is not: it is not synonymous with iron deficiency, not always caused by nutrition, not always symptomatic, and not a diagnosis in itself. It’s a marker that requires investigation to identify the underlying cause.
How the Body Makes – and Destroys – Red Blood Cells
Understanding anemia requires understanding normal red blood cell physiology.
Red blood cells are produced in the bone marrow through a process called erythropoiesis, which is driven by the hormone erythropoietin (EPO) – produced mainly by the kidneys in response to low oxygen levels. This is why kidney disease causes anemia: damaged kidneys can’t produce adequate EPO to drive RBC production.
Each RBC lives for approximately 120 days. The spleen and liver continuously remove old and damaged RBCs (extravascular hemolysis), while the bone marrow replaces them at a matched rate. When production falls, losses increase, or destruction accelerates, the balance tips and anemia develops.
The body’s adaptive response to anemia – regardless of cause – involves increasing cardiac output (heart works harder), redistributing blood flow to vital organs, and at the tissue level, releasing oxygen from hemoglobin more readily (right-shifting the oxygen-hemoglobin dissociation curve). This is why people with slowly developing anemia can function remarkably well at hemoglobin levels that would cause acute collapse if reached suddenly.
The Three-Category Framework: Production, Loss, Destruction
Every case of anemia can be understood through one of three fundamental mechanisms:
1. Reduced Red Blood Cell Production
The bone marrow isn’t making enough RBCs, or isn’t making them correctly. This is the most common mechanism overall.
Sub-categories:
- Nutritional deficiency: Iron (the most common cause globally), vitamin B12, folate – all required for normal RBC synthesis
- Bone marrow suppression: Aplastic anemia (immune-mediated marrow failure), infiltration by cancer (leukemia, multiple myeloma, metastatic solid tumors), or myelodysplastic syndromes
- Reduced EPO stimulation: Chronic kidney disease (CKD) – one of the most common causes of normocytic anemia in adults over 60
- Anemia of chronic disease/inflammation: Inflammatory cytokines suppress erythropoiesis and sequester iron in storage cells (macrophages), reducing its availability for RBC production. Seen with chronic infections, autoimmune diseases, and cancer.
- Sideroblastic anemia: The bone marrow has iron but can’t incorporate it properly into hemoglobin – caused by genetic conditions, alcohol, lead toxicity, or certain medications
2. Blood Loss (Hemorrhage)
Acute blood loss (trauma, surgery, gastrointestinal bleeding) causes sudden hemoglobin drop. The body replaces plasma volume rapidly, diluting the remaining RBCs and making anemia apparent on a CBC. Chronic blood loss – particularly from gastrointestinal sources or heavy menstruation – depletes iron stores over time, eventually producing iron deficiency anemia.
Unexplained iron deficiency anemia in a man of any age or a postmenopausal woman should be evaluated for gastrointestinal blood loss, including colorectal cancer, until proven otherwise. This is a critical clinical red flag that is often insufficiently emphasized in patient-facing materials.
3. Increased Red Blood Cell Destruction (Hemolysis)
RBCs are being destroyed faster than the bone marrow can replace them. The marrow may be working at maximum capacity – reflected in a high reticulocyte count – but can’t keep up with the destruction rate.
Causes of hemolytic anemia include:
- Immune-mediated: Autoimmune hemolytic anemia (warm or cold antibody type), drug-induced hemolysis, transfusion reactions, hemolytic disease of the newborn
- Inherited RBC defects: Sickle cell disease (abnormal hemoglobin structure causes RBCs to deform and be destroyed), hereditary spherocytosis, thalassemias (reduced globin chain production)
- Enzyme deficiencies: G6PD deficiency – the most common RBC enzyme defect, affecting approximately 400 million people globally; typically precipitated by oxidative stress from infections, certain foods (fava beans), or medications (primaquine, dapsone)
- Mechanical destruction: RBCs physically shredded by abnormal heart valves, blood clots in small vessels (TTP, HUS), or severe burns
- Infections: Malaria destroys RBCs directly; certain bacteria also cause hemolysis
The MCV Framework: How the CBC Points to the Cause
The most useful initial step after identifying anemia on a CBC is looking at the mean corpuscular volume (MCV) – the average size of red blood cells. Size is one of the most powerful clues to the underlying mechanism.
Microcytic anemia (MCV below 80 fL) – small red cells:
Small red cells are produced when there’s inadequate hemoglobin to fill a normal-sized cell – either from iron deficiency (not enough iron for hemoglobin synthesis) or thalassemia (not enough globin chains). The differential also includes lead poisoning and sideroblastic anemia.
The two most important causes to distinguish:
- Iron deficiency anemia: Low ferritin, high TIBC, low transferrin saturation
- Thalassemia trait: Normal ferritin, normal iron studies, characteristically high RBC count relative to the low hemoglobin (Mentzer index: MCV/RBC count below 13 suggests thalassemia; above 13 suggests iron deficiency)
Normocytic anemia (MCV 80-100 fL) – normal-sized cells:
This is the most common pattern in hospitalized patients and in chronic illness. Normal-sized cells suggest the problem isn’t with hemoglobin synthesis or cell maturation, but with production rate or survival.
Common causes: anemia of chronic disease, chronic kidney disease, early iron deficiency (before cells shrink), acute blood loss, hemolytic anemia, hypothyroidism, aplastic anemia, bone marrow infiltration.
The reticulocyte count is particularly valuable here: a high reticulocyte count (reticulocytosis) points toward blood loss or hemolysis (the marrow is responding appropriately); a low or inappropriately normal reticulocyte count points toward underproduction.
Macrocytic anemia (MCV above 100 fL) – large cells:
Large cells are produced when RBC maturation is impaired. The cell keeps growing but can’t divide properly. Most commonly caused by vitamin B12 or folate deficiency (megaloblastic anemia – both required for DNA synthesis). Also caused by alcohol (direct toxicity to developing RBCs), liver disease, hypothyroidism, and certain medications (methotrexate, hydroxyurea, azathioprine, some antiretrovirals).
The blood smear in megaloblastic anemia shows hypersegmented neutrophils (white blood cells with 5 or more nuclear lobes) – one of the most specific findings in clinical hematology.
| MCV Category | Common Causes | Key Additional Tests |
|---|---|---|
| Low (microcytic) | Iron deficiency, thalassemia, lead toxicity | Ferritin, iron studies, hemoglobin electrophoresis |
| Normal (normocytic) | CKD, chronic disease, blood loss, hemolysis | Reticulocyte count, kidney function, hemolysis markers |
| High (macrocytic) | B12/folate deficiency, alcohol, liver disease, drugs | B12, folate, LFTs, MMA, reticulocyte count |
Symptoms: What Anemia Actually Feels Like
Symptoms depend more on the rate of development and the degree of severity than on the specific cause. The body adapts to slowly developing anemia far better than to acute drops in hemoglobin.
Mild anemia (Hgb 10-12 g/dL): Often asymptomatic, particularly if developed gradually. May cause mild fatigue with exertion or reduced exercise tolerance.
Moderate anemia (Hgb 8-10 g/dL): Fatigue, reduced exercise capacity, dyspnea (shortness of breath) on exertion, palpitations during activity.
Severe anemia (Hgb below 8 g/dL): Fatigue at rest, dyspnea at rest, resting tachycardia, lightheadedness, pallor, angina (chest pain) in those with underlying coronary artery disease.
Very severe anemia (Hgb below 5-6 g/dL): Risk of high-output heart failure, altered consciousness, cardiovascular collapse.
Specific symptoms by cause:
- Iron deficiency: Pica (craving non-food substances – ice, dirt, chalk, paper), restless legs syndrome, brittle nails, koilonychia (spoon-shaped nails), angular cheilitis (cracks at corners of mouth)
- B12 deficiency: Neurological symptoms (peripheral neuropathy, cognitive changes) – may precede or occur without anemia
- Hemolytic anemia: Jaundice, dark urine (from hemoglobin in urine – hemoglobinuria), splenomegaly
- Thalassemia major: Skeletal deformities from massive marrow expansion in severe untreated disease
Diagnosis: What Gets Ordered and Why
The Complete Blood Count (CBC) is the starting point, providing hemoglobin, hematocrit, RBC count, MCV, MCH (mean corpuscular hemoglobin), MCHC, and RDW (red cell distribution width – a measure of size variability).
Peripheral blood smear – microscopic examination of blood – adds morphological detail that numbers alone can’t capture: hypersegmented neutrophils (megaloblastic), target cells (liver disease, thalassemia), sickle cells, spherocytes, schistocytes (fragmented cells in TTP/HUS).
Reticulocyte count – distinguishes hyperproliferative (hemolysis/blood loss) from hypoproliferative (underproduction) anemia.
Iron studies (ferritin, serum iron, TIBC, transferrin saturation) – essential for microcytic anemia and for distinguishing iron deficiency from anemia of chronic disease.
B12, folate, MMA, homocysteine – for macrocytic anemia evaluation.
Kidney function (creatinine, eGFR) – CKD is a major cause of normocytic anemia.
Thyroid function (TSH) – hypothyroidism causes macrocytic or normocytic anemia.
Hemolysis markers (LDH, haptoglobin, indirect bilirubin, direct Coombs test) – when hemolysis is suspected.
Hemoglobin electrophoresis – when thalassemia or hemoglobinopathy (sickle cell) is suspected.
Who Is at Greatest Risk
Anemia is not evenly distributed. The highest-risk populations:
- Women of reproductive age: Heavy menstrual bleeding is the most common cause of iron deficiency in this group; iron requirements double in pregnancy
- Pregnant women: Iron, folate, and B12 requirements increase substantially; anemia in pregnancy is associated with preterm birth, low birth weight, and maternal mortality in severe cases
- Infants and young children: Rapid growth creates high iron demand; exclusively breastfed infants need iron supplementation after 4-6 months
- Older adults: Multi-factorial – often involves chronic disease, kidney disease, nutritional insufficiency, and myelodysplastic syndromes; anemia in older adults is associated with increased mortality, hospitalizations, and functional decline
- People with chronic diseases: CKD, inflammatory bowel disease, rheumatoid arthritis, heart failure, cancer
- Vegetarians and vegans: Non-heme iron from plant sources is less bioavailable; B12 absent from plant foods without supplementation
- Frequent blood donors: Regular donation can deplete iron stores over time
Frequently Asked Questions
Can anemia be cured by eating more iron-rich foods? For mild iron deficiency from dietary causes, improving dietary iron intake can help – but it’s rarely sufficient on its own for moderate or severe deficiency, which typically requires supplemental iron. More importantly, before assuming diet is the cause, the reason for iron deficiency needs to be established – particularly in men and postmenopausal women where blood loss from the gastrointestinal tract must be excluded.
My hemoglobin is 11.5 g/dL. Is that serious? It depends on who you are. In a non-pregnant woman, this is mildly below normal (threshold 12.0 g/dL) and may cause minimal or no symptoms. In a pregnant woman (threshold 11.0 g/dL) it’s borderline normal. The severity of anemia matters less than the cause – a mild hemoglobin drop from colorectal cancer bleeding is more urgent than a mildly low hemoglobin from heavy periods, even if the numbers look similar.
Is fatigue always a sign of anemia? No – fatigue is one of the most non-specific symptoms in medicine, with hundreds of potential causes. Anemia does cause fatigue, but not every fatigued person is anemic. The only way to determine whether anemia is contributing to fatigue is through a blood test.
Can anemia affect the heart? Significantly. Anemia forces the heart to increase cardiac output to compensate for reduced oxygen delivery per unit of blood. In people with already-compromised heart function, even mild anemia can precipitate heart failure or angina. In severe anemia, a previously healthy heart can develop high-output heart failure. This is why anemia in elderly patients and those with cardiovascular disease warrants particularly prompt attention.
Should I take iron supplements without being tested first? No. Iron supplementation is appropriate only when iron deficiency has been confirmed by testing. Taking iron without a diagnosis can mask blood loss (the ferritin rises from supplementation even if bleeding continues), cause gastrointestinal side effects unnecessarily, and in people with iron overload conditions (hereditary hemochromatosis), cause serious harm. Get tested first.
Disclaimer
This article is for educational purposes only and does not constitute medical advice. Anemia should be properly investigated by a qualified healthcare provider to identify the underlying cause before any treatment is initiated. Do not self-diagnose or self-treat anemia based on symptoms or this content alone.
References
- Camaschella C. Iron-deficiency anemia. New England Journal of Medicine. 2015;372(19):1832-1843. https://doi.org/10.1056/NEJMra1401038
- World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. 2011. https://www.who.int/publications/i/item/WHO-NMH-NHD-MNM-11.1
- National Heart, Lung, and Blood Institute (NHLBI). Anemia. https://www.nhlbi.nih.gov/health/anemia
- Kassebaum NJ, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood. 2014;123(5):615-624. https://doi.org/10.1182/blood-2013-06-508325
- Tefferi A. Anemia in adults: a contemporary approach to diagnosis. Mayo Clinic Proceedings. 2003;78(10):1274-1280. https://doi.org/10.4065/78.10.1274
- American Society of Hematology. Anemia. https://www.hematology.org/education/patients/anemia
- MedlinePlus – National Library of Medicine. Anemia. https://medlineplus.gov/anemia.html
- Ganz T. Anemia of inflammation. New England Journal of Medicine. 2019;381(12):1148-1157. https://doi.org/10.1056/NEJMra1903513
- Centers for Disease Control and Prevention (CDC). Iron deficiency anemia. https://www.cdc.gov/nutrition/micronutrient-malnutrition/iron/index.html
- Stabler SP. Vitamin B12 deficiency. New England Journal of Medicine. 2013;368(2):149-160. https://doi.org/10.1056/NEJMcp1113996
3 Comments